ALEMBIC PHARMACEUTICALS LTD. - 533573 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') - Disruption Of Operations At The Company'S Manufacturing Facilities At Sikkim Due To Flash Floods.

Alembic Pharmaceuticals Ltd.

NSE: APLLTD | BSE: 533573 | ISIN: INE901L01018 | Industry: Pharmaceuticals
| Mid-range Performer

958.8000 -10.40 (-1.07%)

NSE Jun 18, 2025 15:31 PM

26.47% Fall from 52W High

Volume: 84,492

Alembic Pharmaceuticals Ltd.

04 Oct 2023

958.80

-1.07%

Company Update

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure …

BSE India

Please find enclosed the intimation for disruption of operation at the Company''s manufacturing Facility at Sikkim due to flash flood

More from Alembic Pharmaceuticals Ltd.

Recommended

Chart of the Week: Profit booking grips promoters as stake sales surge across sectors

The Baseline | 18 Jun 2025, 05:06PM

Market closes lower, HDFC Bank CEO challenges FIR over disputed loan disclosure

Trendlyne Marketwatch | 18 Jun 2025, 03:58PM

Earnings Call Transcript - Q1FY21 for Alembic Pharmaceuticals